281 related articles for article (PubMed ID: 28426665)
1. Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.
Peterson TA; Gauran IIM; Park J; Park D; Kann MG
PLoS Comput Biol; 2017 Apr; 13(4):e1005428. PubMed ID: 28426665
[TBL] [Abstract][Full Text] [Related]
2. Domain landscapes of somatic mutations in cancer.
Peterson TA; Park D; Kann MG
AMIA Jt Summits Transl Sci Proc; 2013; 2013():136. PubMed ID: 24303323
[TBL] [Abstract][Full Text] [Related]
3. Domain landscapes of somatic mutations in cancer.
Nehrt NL; Peterson TA; Park D; Kann MG
BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
[TBL] [Abstract][Full Text] [Related]
5. Protein domain-level landscape of cancer-type-specific somatic mutations.
Yang F; Petsalaki E; Rolland T; Hill DE; Vidal M; Roth FP
PLoS Comput Biol; 2015 Mar; 11(3):e1004147. PubMed ID: 25794154
[TBL] [Abstract][Full Text] [Related]
6. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
[TBL] [Abstract][Full Text] [Related]
7. Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants.
Grillo E; Ravelli C; Corsini M; Zammataro L; Mitola S
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188614. PubMed ID: 34403770
[TBL] [Abstract][Full Text] [Related]
8. Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census.
Malhotra S; Alsulami AF; Heiyun Y; Ochoa BM; Jubb H; Forbes S; Blundell TL
PLoS One; 2019; 14(7):e0219935. PubMed ID: 31323058
[TBL] [Abstract][Full Text] [Related]
9. The mutational landscape of phosphorylation signaling in cancer.
Reimand J; Wagih O; Bader GD
Sci Rep; 2013 Oct; 3():2651. PubMed ID: 24089029
[TBL] [Abstract][Full Text] [Related]
10. A protein domain-centric approach for the comparative analysis of human and yeast phenotypically relevant mutations.
Peterson TA; Park D; Kann MG
BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S5. PubMed ID: 23819456
[TBL] [Abstract][Full Text] [Related]
11. Incorporating molecular and functional context into the analysis and prioritization of human variants associated with cancer.
Peterson TA; Nehrt NL; Park D; Kann MG
J Am Med Inform Assoc; 2012; 19(2):275-83. PubMed ID: 22319177
[TBL] [Abstract][Full Text] [Related]
12. Detection of somatic mutations in tumors using unaligned clonal sequencing data.
Sutton KM; Crinnion LA; Wallace D; Harrison S; Roberts P; Watson CM; Markham AF; Bonthron DT; Quirke P; Carr IM
Lab Invest; 2014 Oct; 94(10):1173-83. PubMed ID: 25068661
[TBL] [Abstract][Full Text] [Related]
13. Protein-structure-guided discovery of functional mutations across 19 cancer types.
Niu B; Scott AD; Sengupta S; Bailey MH; Batra P; Ning J; Wyczalkowski MA; Liang WW; Zhang Q; McLellan MD; Sun SQ; Tripathi P; Lou C; Ye K; Mashl RJ; Wallis J; Wendl MC; Chen F; Ding L
Nat Genet; 2016 Aug; 48(8):827-37. PubMed ID: 27294619
[TBL] [Abstract][Full Text] [Related]
14. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
15. Computational approaches to identify functional genetic variants in cancer genomes.
Gonzalez-Perez A; Mustonen V; Reva B; Ritchie GR; Creixell P; Karchin R; Vazquez M; Fink JL; Kassahn KS; Pearson JV; Bader GD; Boutros PC; Muthuswamy L; Ouellette BF; Reimand J; Linding R; Shibata T; Valencia A; Butler A; Dronov S; Flicek P; Shannon NB; Carter H; Ding L; Sander C; Stuart JM; Stein LD; Lopez-Bigas N;
Nat Methods; 2013 Aug; 10(8):723-9. PubMed ID: 23900255
[TBL] [Abstract][Full Text] [Related]
16. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
17. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
18. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
Sun S; Thorson JA; Murray SS
Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
[TBL] [Abstract][Full Text] [Related]
19. A computational and structural analysis of germline and somatic variants affecting the DDR mechanism, and their impact on human diseases.
Magraner-Pardo L; Laskowski RA; Pons T; Thornton JM
Sci Rep; 2021 Jul; 11(1):14268. PubMed ID: 34253785
[TBL] [Abstract][Full Text] [Related]
20. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
